Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

OTHER × Prostate Cancer Recurrent × Sirolimus × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Other solid neoplasm 1 Genitourinary 1

Conditions

Precursor Cell Lymphoblastic Leukemia-Lymphoma 29 Leukemia, Myeloid, Acute 27 Myelodysplastic Syndromes 26 Hodgkin Disease 23 Multiple Myeloma 22 Lymphoma, Non-Hodgkin 22 Lymphoma 20 Leukemia 20 Leukemia, Lymphocytic, Chronic, B-Cell 19 Graft vs Host Disease 19 Leukemia, Myelogenous, Chronic, BCR-ABL Positive 15 Myeloproliferative Disorders 14 Lymphoma, Mantle-Cell 14 Tuberous Sclerosis 12 Neoplasms 12 Lymphoma, Large B-Cell, Diffuse 12 Burkitt Lymphoma 12 Primary Myelofibrosis 11 Hematologic Neoplasms 11 Recurrence 10 Neoplasms, Plasma Cell 10 Lymphoma, Follicular 10 Leukemia, Myelomonocytic, Chronic 10 Waldenstrom Macroglobulinemia 9 Neoplasm Metastasis 9 Lymphoma, B-Cell, Marginal Zone 9 Lymphangioleiomyomatosis 9 Leukemia, Myeloid, Chronic-Phase 9 Leukemia, Myeloid, Accelerated Phase 9 Breast Neoplasms 9

Interventions

acetyl-2-naphthylalanyl-3-chlorophenylalanyl-1-oxohexadecyl-seryl-4-aminophenylalanyl(hydroorotyl)-4-aminophenylalanyl(carbamoyl)-leucyl-ILys-prolyl-alaninamide 1 Sirolimus 1 Nelfinavir 1 Metformin 1 Hydroxychloroquine 1 Diet, Protein-Restricted 1 Dasatinib 1 Blood Specimen Collection 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05036226 2025-10-06

COAST

Medical University of South Carolina

Phase 1/2 Recruiting

GenitourinaryOther solid neoplasm

Prostate Cancer Recurrent

Data powered by HemOnc (CC BY 4.0) Colophon ⚡